Search results for

There are two competing trends: The population of the U.S. has grown at the same time as the workforce of the IRS has shrunk. A 10-year, $80 billion plan aims to tackle the agency's troubles.

Patients taking diabetes drug Ozempic or the weight-loss drug Wegovy are reporting a curious, beneficial side effect. The drugs seem to reduce people's cravings for alcohol, nicotine and even opioids.

Nearly a year ago, Florida enacted one of the most strict immigration laws in the nation. Many local businesses say it has hurt their bottom line.

Throughline, brings us the story of Israeli Prime Minister Benjamin Netayahu's political ascent and the right-wing ideologies that have informed his current stance on Gaza and the state of Israel.

Ukrainian officials and power companies are preparing for Russia to ramp up its attacks on energy infrastructure again as temperatures dip.

In a matter of a few years in the 1960s, Dick Van Dyke became a star on Broadway, television and the silver screen.

Millions of people with Medicare are now eligible to get discounted GLP-1 drugs for weight loss under a special program. Here's how it will work.

More than 40 million adults in the U.S. ages 50 and older have osteopenia, or low bone density. An FDA-approved wearable vibration device is giving some women a tool that could slow that loss.

Democrats see an opportunity in Texas to retake the Senate, but how realistic is that goal? NPR's A Martinez speaks with Kyle Kondik {KAHN-dik} of the University of Virginia Center for Politics.

A trio of Senate Republicans are on their way out of Congress. Each has previously drawn President Trump's scorn and now each are seen as newly liberated to complicate his agenda if they choose.